Jill Carroll Insider Profile
11 Followers
Jill Carroll, Director at Avalyn Pharma Inc, holds 2.19M shares in Avalyn Pharma Inc (Ticker: AVLN), holds 0.00 shares in Arcellx Inc (Ticker: ACLX), holds 0.00 shares in Pandion Therapeutics (Ticker: PAND).
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
+6.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Jill Carroll holds in companies
Most Profitable Insider Trade
Stock:
Arcellx Inc
(ACLX)
(ACLX)
Rating:Informative Buy
Date:Feb 09, 2022 - Feb 09, 2023
Return:+85.40%
The most profitable trade made by Jill Carroll
Jill Carroll's Trading History
Avalyn Pharma Inc
May 01, 2026
Director
Uninformative Buy
―
$81.76M
Applied Genetic Technologies
Apr 01, 2014
―
Informative Buy
1.25M
$781.91K
Pandion Therapeutics
Apr 01, 2021
―
Uninformative Sell
340.45M
$0.00
Arcellx Inc
Apr 28, 2026
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Jill Carroll's performance on stock
You May Also Like
Jill Carroll insider profile FAQ
What is the percentage of profitable transactions made by Jill Carroll?
The percentage of profitable transactions made by Jill Carroll is 43%.
What is the average return per transaction made by Jill Carroll?
The average return per transaction made by Jill Carroll is 6.20%.
What stocks does Jill Carroll hold?
Jill Carroll holds: AVLN, AGTC, PAND, ACLX stocks.
What was Jill Carroll’s latest transaction?
Jill Carroll latest transaction was an Uninformative Buy of ―.
What was Jill Carroll's most profitable transaction?
Jill Carroll’s most profitable transaction was an Informative Buy of ACLX stock on February 9, 2022. The return on the trade was 85.40%.
What is Jill Carroll's role in Avalyn Pharma Inc?
Jill Carroll's role in Avalyn Pharma Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.